Novo

Vision Loss Claims Spark Multicounty Litigation Push Against Novo Nordisk’s Weight Loss Drugs

by

Following a recent wave of lawsuits, more than 20 plaintiffs have come together in New Jersey state court, alleging that Novo Nordisk’s popular weight loss drugs are linked to severe vision loss. These individuals have formally requested that their cases be classified as multicounty litigation, as detailed in a notice issued to the bar this past Monday. The legal move aims to consolidate similar claims and streamline the judicial process. The plaintiffs, suffering from alleged eyesight complications, are focusing on potential links between the medication and their health issues. Patients have expressed concern that the … Read more

Patients Seek Compensation in Ozempic Lawsuit Claims Against Novo Nordisk

by

Patients who have experienced severe side effects from the diabetes drug Ozempic are filing lawsuits against Novo Nordisk, claiming that the pharmaceutical company failed to warn them about the potential risks. While Ozempic is only approved by the FDA for treating type 2 diabetes, it has been used off-label for weight loss due to its effectiveness in reducing appetite and producing a feeling of fullness. However, the drug has been associated with various side effects, including gastroparesis (stomach paralysis), thyroid tumors or cancer, hypoglycemia, pancreatitis, and gallstones. The exact worth of each Ozempic claim is … Read more